Showing 137 news articles about Resistance

Filters Content type: Editors' picks Topic: Resistance

Poor adherence and the subsequent development of drug resistance is one reason why HIV treatment can fail. A drug-resistant HIV strain is one which is less susceptible to the effects of one or more anti-HIV drugs.

Resistance

Darunavir Resistance Development Is Rare in HIV Treatment

Editor's pick
Infectious Disease Advisor
1 September 2020
Resistance

Doravirine Benefits HIV-1 Patients with Common Resistance Associated Mutations

Editor's pick
Contagion Live
8 July 2020
HIV treatment for children & young people

Combatting Virologic Failure in Children with HIV using Targeted Drug Resistance Testing

Editor's pick
Contagion Live
8 July 2020
Resistance

HIV drugs have transformed the lives of people in rich nations. In Papua New Guinea, the virus is mutating

Editor's pick
ABC
22 June 2020
Adherence

US: Factors Contributing to Poor ART Adherence, HIV-1 Drug Resistance Explored

Editor's pick
Monthly Prescribing Reference
16 June 2020
Resistance

How HIV develops resistance to key drugs discovered

Editor's pick
EurekAlert
31 January 2020
Resistance

WHO unveils plan to tackle rising HIV drug resistance in Africa

Editor's pick
World Health Organization
9 December 2019
New & experimental HIV treatments

ViiV Healthcare submits New Drug Application to the FDA for fostemsavir, an investigational, first-in-class attachment inhibitor for the treatment of HIV in adults with few treatment options available

Editor's pick
5 December 2019
HIV treatment

Top 10 HIV Clinical Developments of 2019

Editor's pick
TheBodyPro
27 November 2019
Resistance

FDA authorizes marketing of first next-generation sequencing test for detecting HIV-1 drug resistance mutations

Editor's pick
Food & Drug Administration
6 November 2019
Changing treatment

‘Alarming’ rates of second-line HIV treatment failure in sub-Saharan Africa

Editor's pick
Avert
22 August 2019
Resistance

Alarming surge in drug-resistant HIV uncovered

Editor's pick
Nature
3 August 2019
People with limited treatment options

Clinical and Economic Effects of Ibalizumab for Multidrug-Resistant HIV

Editor's pick
Infectious Disease Advisor
2 August 2019
People with limited treatment options

EMA panel recommends ibalizumab for multidrug-resistant HIV-1

Editor's pick
Medscape (requires free registration)
30 July 2019
Changing treatment

Biktarvy Suppresses HIV Well in Women and Those With Drug Resistance

Editor's pick
POZ
29 July 2019
Resistance

WHO: Pretreatment HIV drug resistance exceeds 10% in many places

Editor's pick
Healio
24 July 2019
People with limited treatment options

AIDS Conference Returns to Mexico City, Where We Saw an Underrated, Great Advance in HIV Therapy

Editor's pick
NEJM Journal Watch
24 July 2019
Changing treatment

Drug-Resistance Mutations May Curb Efficacy of Dolutegravir-Based Regimens in Zimbabwe Teens With HIV

Editor's pick
Medscape (free registration required)
7 July 2019
Resistance

Genotype Testing at HIV Diagnosis Provides No Benefit

Editor's pick
Infectious Disease Advisor
25 June 2019
Opportunistic infections

A Mysterious Infection, Spanning the Globe in a Climate of Secrecy

Editor's pick
New York Times
8 April 2019
People with limited treatment options

Can high-dose dolutegravir be a rescue therapy?

Editor's pick
CATIE
12 March 2019
Sexually transmitted infections prevention

Should we be concerned some gay men are buying antibiotics online for STIs?

Editor's pick
Gay Star News
28 December 2018
Resistance

Resistance to second-line ARTs increasing in South Africa

Editor's pick
Medical Brief
14 December 2018
Resistance

Uganda:15 Percent HIV-Positive Ugandans Resistant to Drugs - Report

Editor's pick
AllAfrica
13 September 2018